Latest News and Press Releases
Want to stay updated on the latest news?
-
RESS RELEASE Information on the total number of voting rights and shares – additional thresholds Liège (Belgium), 30 June 2020, 9h00 (CEST) – regulated information – In accordance with article 15 of...
-
Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
This announcement does not constitute an offer to sell, or an invitation to offer or buy or subscribe for, securities. An investment in the Offered Shares involves substantial risks and uncertainties....
-
This announcement does not constitute an offer to sell, or an invitation to offer or buy or subscribe for, securities. An investment in the Offered Shares involves substantial risks and uncertainties....
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SWITZERLAND, ISRAEL, JAPAN OR SOUTH AFRICA This announcement does not constitute an...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SWITZERLAND, ISRAEL, JAPAN OR SOUTH AFRICA This announcement does not constitute an offer to...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SWITZERLAND, ISRAEL, JAPAN OR SOUTH AFRICA This announcement does not constitute an offer to...
-
This announcement does not constitute an offer to sell, or an invitation to offer or buy or subscribe for, securities. An investment in the offered shares involves substantial risks and uncertainties....
-
Hyloris Pharmaceuticals SA (“Hyloris” or the “Company”) Hyloris appoints Patrick Jeanmart as Chief Financial Officer Liège, Belgium – 26 May 2020: Hyloris Pharmaceuticals SA, an innovative...
-
Hyloris Pharmaceuticals SA (“Hyloris” or the “Company”) Hyloris Pharmaceuticals successfully raises €15 million in funding round Liège, Belgium, – 30 April 2020: Hyloris Pharmaceuticals SA, an...